Incannex website
Web1 day ago · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs is pleased to announce that is has appointed Quest Pharmaceutical … WebApr 21, 2024 · Website: www.incannex.com.au Investors: [email protected] Forward-looking statements This press release contains "forward-looking statements" within the meaning …
Incannex website
Did you know?
WebAug 2, 2024 · Incannex Chief Scientific Officer Dr Mark Bleackley said; "Scaling up cGMP manufacture of IHL-216A is an exciting step in the development of our product and represents a critical milestone for ... WebMar 14, 2024 · “The results from the interim analysis of Incannex’s Phase 2 clinical trial provide us with encouragement that our PsiGAD psilocybin-assisted psychotherapy treatment protocol has the potential to transform the lives of people suffering from anxiety," Incannex Healthcare CEO and managing director Joel Latham said.
WebFeb 28, 2024 · SYDNEY, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing proprietary... WebJul 21, 2024 · Incannex is listed on the Australian Stock Exchange (ASX) with stock code "IHL" and also has American Depository Shares listed on NASDAQ under code "IXHL". …
Web1 day ago · Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has secured the aid of Quest Pharmaceutical Services to provide regulatory advice and manage clinical trials for the … WebApr 14, 2024 · Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid …
WebApr 14, 2024 · MELBOURNE, Australia, April 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic assisted psychotherapies for unmet medical needs, is pleased to announce that is has appointed …
WebJul 27, 2024 · Incannex Healthcare Limited. Jul 27, 2024, 07:55 ET. MELBOURNE, Australia, July 27, 2024 /PRNewswire/ -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL ... dhs research libraryWeb1 day ago · Melbourne, Australia, April 14, 2024 - Incannex Healthcare Ltd (Nasdaq: IXHL). (ASX: IHL) ('Incannex' or 'the Company') a pharmaceutical company developing proprietary … dhs research and development projectsWebGet the latest Incannex Healthcare Ltd (IHL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … cincinnati omni netherland hotelWebMar 17, 2024 · Incannex Healthcare is a clinical-stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalised anxiety disorder (GAD), obstructive sleep apnoea (OSA), traumatic brain injury (TBI)/concussion, lung … dhs residential fires indianaWebOct 13, 2024 · MELBOURNE, Australia, Oct. 13, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing... cincinnati open 2019 playersWebGet the latest Incannex Healthcare ADR (IXHL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … cincinnati on the leveeWebIncannex Healthcare Ltd (IHL) Stock Price & News - Google Finance Home IHL • ASX Incannex Healthcare Ltd Follow Share $0.14 Apr 4, 5:22:01 AM GMT+10 · AUD · ASX · Disclaimer search Compare to... dhs research grants